Unity Health Toronto

Quick facts

Marketed products

• furosemide administration · Cardiovascular
  Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid volume.
• Meropenem Infusion · Infectious Disease
  Meropenem is a broad-spectrum beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.
• Nitrous Oxide 99 % · Anesthesia
  Nitrous oxide acts as a dissociative anesthetic and analgesic by antagonizing N-methyl-D-aspartate (NMDA) receptors in the central nervous system.
• Nitrous oxide gas for inhalation · Anesthesia and Acute Pain Management
  Nitrous oxide acts as a dissociative anesthetic and analgesic by modulating NMDA receptor activity and enhancing inhibitory neurotransmission in the central nervous system.
• Oxygen + Midazolam · Anesthesia/Procedural Sedation
  Oxygen increases blood oxygen saturation while midazolam provides sedation and anxiolysis via GABA-A receptor modulation.
• Rectal Methadone administer during spinal surgery
• Saliva collection
  Saliva collection is a diagnostic specimen collection procedure, not a drug with a pharmacological mechanism.
• Semaglutide Pen
• Topical timolol maleate · Ophthalmology
  Topical timolol maleate is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye.
• Whole Blood
• Withdrawal of furosemide · Cardiovascular
  Withdrawal of furosemide allows restoration of normal fluid and electrolyte balance by discontinuing loop diuretic activity.
• Zoloft (antidepressant) · Psychiatry / Neurology
  Zoloft selectively blocks the reuptake of serotonin in the brain, increasing serotonin availability at synapses.

Phase 3 pipeline

• Therapeutic Anticoagulation · Cardiovascular
  Therapeutic anticoagulation involves the inhibition of blood clot formation to prevent thrombotic events.

Phase 2 pipeline

• Biomarker Testing
• Intravitreal topotecan · Oncology
  Topoisomerase I inhibitor
• nPEP
• Saliva Samples
• Vaginal and blood sample collection

Phase 1 pipeline

• Urine sample collection

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Unity Health Toronto portfolio CI brief
• Unity Health Toronto pipeline updates RSS